← Open Payments lookup

AMANDA STEMLER: Open Payments

NPI 1427700541 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$658 in 33 payments from 10 companies in 2025. Trend: 2023 $663 · 2024 $946 · 2025 $658

Food & beverage: $658
CompanyPaymentsAmount
Biogen, Inc.8$200
Astellas Pharma US Inc8$166
Sumitomo Pharma America, Inc.4$87
MAYNE PHARMA COMMERCIAL LLC3$53
Pharmacosmos Therapeutics Inc.2$38
Radius Health, Inc.2$30
Exeltis, USA Inc.2$30
Organon LLC2$22
ABBVIE INC.1$18
Amgen Inc.1$14

Products named: ZURZUVAE, Veozah, GEMTESA, MONOFERRIC, Tymlos, SLYND, MYFEMBREE, NEXPLANON.

Industry payments across IN — which companies pay providers there.